Our business includes CDMO business providing research, product development and manufacturing services. We were third fastest growing CDMO in terms of Operating Income over the period Fiscal 2019 to Fiscal 2023 and positioned our Company to benefit from the growth in the CDMO market by developing strong R&D and manufacturing operations for our customers to support their domestic sales and exports to certain markets.

Fourteen of the top fifteen Indian pharmaceutical companies that CRISIL Research identified as the largest players in the domestic formulation market in Fiscal 2023 have been a part of our customer base.

Our Capabilities

• World class manufacturing facilities in Baddi, Himachal Pradesh and Our manufacturing facilities have good manufacturing practices certifications in conformity with the format recommended by WHO-GMP, EU-GMP and many other international authorities.
• Strong R&D focus to build an increasingly complex product portfolio and attract and retain customers.
• Our CDMO product portfolio spans across both acute and chronic therapeutic areas.
• Leading presence and one of the fastest growing CDMOs in the Indian pharmaceutical formulations market.
• Well established relationships with our marquee CDMO customer base.

Our strength in CDMO sphere includes:

• Our comprehensive CDMO formulation capabilities allow us to offer our customers multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, as well as more complex delivery forms such as modified and sustained release forms and tablets in capsules.
• We manufacture products that are in all the top ten therapeutic areas by sales in the Indian formulation market in Fiscal 2023 as identified by CRISIL Research. We manufacture products across some of the key therapeutic areas.
• Our operational track record in successful delivery of products, R&D, quality and technical standards and productivity.
• Strong R&D and manufacturing operations for our customers to support their domestic sales and exports to certain markets.
• Our R&D laboratory is equipped with the entire suite of necessary equipment for the development of solid oral and liquid dosage forms.